Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma

MLA

Nobukazu Fujimoto, and Katsuyuki Hotta. “Current Evidence and Future Perspectives of Immune-Checkpoint Inhibitors in Unresectable Malignant Pleural Mesothelioma.” Journal for ImmunoTherapy of Cancer, vol. 8, no. 1, May 2020. EBSCOhost, https://doi.org/10.1136/jitc-2019-000461.

APA

Nobukazu Fujimoto, & Katsuyuki Hotta. (2020). Current evidence and future perspectives of immune-checkpoint inhibitors in unresectable malignant pleural mesothelioma. Journal for ImmunoTherapy of Cancer, 8(1). https://doi.org/10.1136/jitc-2019-000461

Chicago

Nobukazu Fujimoto, and Katsuyuki Hotta. 2020. “Current Evidence and Future Perspectives of Immune-Checkpoint Inhibitors in Unresectable Malignant Pleural Mesothelioma.” Journal for ImmunoTherapy of Cancer 8 (1). doi:10.1136/jitc-2019-000461.